BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15094771)

  • 1. The role of c-myc in regulation of translation initiation.
    Schmidt EV
    Oncogene; 2004 Apr; 23(18):3217-21. PubMed ID: 15094771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of c-myc in cellular growth control.
    Schmidt EV
    Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of translation in neoplastic transformation from a pathologist's point of view.
    Rosenwald IB
    Oncogene; 2004 Apr; 23(18):3230-47. PubMed ID: 15094773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eIF4E--from translation to transformation.
    Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
    Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets and mechanisms for the regulation of translation in malignant transformation.
    Clemens MJ
    Oncogene; 2004 Apr; 23(18):3180-8. PubMed ID: 15094767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5'UTR.
    Carter PS; Jarquin-Pardo M; De Benedetti A
    Oncogene; 1999 Jul; 18(30):4326-35. PubMed ID: 10439040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
    Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
    Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth.
    Lynch M; Fitzgerald C; Johnston KA; Wang S; Schmidt EV
    J Biol Chem; 2004 Jan; 279(5):3327-39. PubMed ID: 14607835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.
    Shih JW; Tsai TY; Chao CH; Wu Lee YH
    Oncogene; 2008 Jan; 27(5):700-14. PubMed ID: 17667941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.
    Zhu N; Gu L; Findley HW; Zhou M
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1272-9. PubMed ID: 16112647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oncogenic potential of the eIF4E-binding proteins.
    Martineau Y; Azar R; Bousquet C; Pyronnet S
    Oncogene; 2013 Feb; 32(6):671-7. PubMed ID: 22508483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of eIF4 in cell proliferation.
    Flynn A; Proud CG
    Cancer Surv; 1996; 27():293-310. PubMed ID: 8909806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
    Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
    Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxins activate translational regulation pathways in intestinal epithelial cells.
    Colpoys WE; Cochran BH; Carducci TM; Thorpe CM
    Cell Signal; 2005 Jul; 17(7):891-9. PubMed ID: 15763431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.